In bid to lower prices, Gottlieb says FDA will take new action to speed approval of biosimilars
The FDA cannot regulate drug prices, but the agency is enacting new policies to speed the testing and approval of generic drugs, commissioner says.
NEW YORK — Scott Gottlieb, the commissioner of the Food and Drug Administration, is a free-market proponent in a fervently anti-regulatory administration who is trying to
